Turbo
Well-Known Member
Interesting article about the science behind the vaccine and the debate on how publicly funded research is being used as the basis for Pfizer and Moderna's vaccine, that they will inevitably cash in on. What should the obligation for these private companies be?
The vaccines made by Pfizer and Moderna, which are likely to be the first to win FDA approval, in particular rely heavily on two fundamental discoveries that emerged from federally funded research: the viral protein designed by Graham and his colleagues, and the concept of RNA modification, first developed by Drew Weissman and Katalin Karikó at the University of Pennsylvania. In fact, Moderna’s founders in 2010 named the company after this concept: “Modified” + “RNA” = Moderna, according to co-founder Robert Langer.
“This is the people’s vaccine,” said corporate critic Peter Maybarduk, director of Public Citizen’s Access to Medicines program. “Federal scientists helped invent it and taxpayers are funding its development. … It should belong to humanity.”
Under a 1980 law, the NIH will obtain no money from the coronavirus vaccine patent. How much money will eventually go to the discoverers or their institutions isn’t clear. Any existing licensing agreements haven’t been publicized; patent disputes among some of the companies will likely last years. HHS’ big contracts with the vaccine companies are not transparent, and Freedom of Information Act requests have been slow-walked and heavily redacted, said Duke University law professor Arti Rai.
Government-Funded Scientists Laid the Groundwork for Billion-Dollar Vaccines - KFF Health News
Drugmakers will walk away with massive profits, but much of the pioneering work on mRNA vaccines was done with government money.khn.org
There was also a great write-up at STAT on the same subject*, if you want to read more.
The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
The story of mRNA began is a tale of personal perseverance, eureka moments in the lab, soaring expectations — and an unprecedented flow of cash in biotech.
www.statnews.com
EDIT: *I should clarify - not same subject exactly - more on the history of the technology behind these vaccines.